Jigni Pathan (MRes Student)

MRes Cancer Biology student was involved in a dynamic research project under the guidance of Dr. Zahraa Al-Aamady, focusing on the identification and targeting of overexpressed genes within multiple myeloma. It delves into the intricate molecular landscape of multiple myeloma (MM), decoding genetic complexities, exploring epigenetic regulations, and investigating gene therapy. My research portfolio is diverse, spanning investigations into the properties of Daboialectin, a significant component of Russell's Viper Venom, and contributions to research on the DRDO-approved Anti-COVID drug 2-Deoxy-D-glucose, showcasing my versatility in biotechnology and natural drug discovery.

Recognition for my contributions includes receiving travel grants for international conferences, notably presenting my research in the Journal of Toxicon, and earning a scholarship for pursuing MRes in Cancer Biology at Nottingham Trent University. Additionally, my entrepreneurial spirit shone through as a runner-up at the BonjourIndia 24H Non-Stop Indo-French Entrepreneurship Challenge, where I actively contributed to the creation of an innovative startup project.

With a strong foundation in cancer biology, diverse research experiences, and a commitment to advancing scientific knowledge, I am poised to make significant contributions to the field.